Author
The University of Texas at AustinORCID 0000-0002-5964-7525Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Adam R. Simard, Noor M Taher, Kathryn S. Beauchemin…·Dean R. Madden
The paper identifies two classes of nanobodies that inhibit Cif, an epoxide hydrolase from Pseudomonas aeruginosa, through distinct structural strategies targeting a shared epitope.
Ahlam N. Qerqez, Katja Hoffmann, Alison G. Lee…·Jennifer A. Maynard
This paper engineers IgG1 antibodies with modified Fc domains to resist viral Fc receptor binding, enhancing NK cell activation and reducing HCMV spread in infected cells.
Olivia S. Shin, Stephanie R. Monticelli, Christy K. Hjorth…·Jason S. McLellan
The paper identifies non-neutralizing antibodies from CCHFV survivors that target multiple regions on GP38, showing protective efficacy in rodent models.